SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Anticipation around Alpha Taus oncology pipelineparticularly further REGAIN glioblastoma data after FDA clearance to expand the trial, alongside pancreatic and other study milestonesis driving attention. Many traders are optimistic about the early signals and upcoming catalysts, while others point to price consolidation and uncertainty about when the next concrete update will arrive.

Select Sector SPDR Trust (The) - State Street Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

Technology-sector weakness and doubts about the returns on heavy AI and data-center spending are driving discussion around XLK, whose concentrated holdings make it vulnerable to swings in mega-cap and semiconductor stocks. Traders point to put-heavy options activity and further downside risk, while others view the pullback as a buying opportunity and debate whether sector rotation is underway.

JasmyCoin (JASMY) is a cryptocurrency launched in 2016and operates on the Ethereum platform. JasmyCoin has a current supply of 50,000,000,000 with 49,444,999,677.16957912 in circulation. The last known price of JasmyCoin is 0.0036376 USD and is down -1.34 over the last 24 hours. It is currently trading on 374 active market(s) with $6,877,222.43 traded over the last 24 hours. More information can be found at https://www.jasmy.co.jp/en_company.html.

JasmyCoin

JASMYs volatile price action is fueling debate over whether its ecosystem developmentsespecially JasmyChains gas-token utility and the AppBank/Money Twin AI partnershipcan lead to real adoption. Bulls point to the partnerships and recent trading momentum, while skeptics cite limited on-chain usage, weak relative performance, and concerns about Janctions rally and exchange-listing rumors.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVSs Q3 earnings beat and higher full-year outlook are being overshadowed by its planned 2028 separation of retail pharmacies from Aetna and Caremark; traders debate whether the breakup will unlock value or create uncertainty around the businesses structure and debt. A reported open-market purchase by an executive is also drawing attention amid the selloff and rebound.

Interactive Brokers Group, Inc. is an investment holding company, which engages in broker or dealer and proprietary trading businesses. It offers custody and service accounts for hedge and mutual funds, exchange-traded funds, registered investment advisors, proprietary trading groups, introducing brokers, and individual investors. The company was founded by Thomas Pechy Peterffy in 1977 and is headquartered in Greenwich, CT.

Interactive Brokers Group Inc - Ordinary Shares - Class A

Interactive Brokers Group Inc 

Interactive Brokers quarterly earnings are driving discussion, with traders weighing strong account growth, net interest income and a higher dividend against softer trading activity and a largely in-line report. Reactions are mixed, ranging from bullish views on the companys growth and profitability to disappointment over the stocks muted post-earnings response.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

Early zugocel autoimmune data showing responses in systemic sclerosis and inflammatory myopathy has drawn attention, with traders emphasizing the therapys reported tolerability and off-the-shelf CAR-T potential while noting the small cohorts and need for follow-up. Discussion also focuses on the forthcoming CTX310 cardiovascular readout, with optimism about another catalyst tempered by questions about whether lipid reductions will translate into clinical benefit.

Select Sector SPDR Trust (The) - State Street Health Care Select Sector SPDR ETF

Health Care Select Sector SPDR Fund

XLV is drawing attention as traders discuss a rotation into healthcare defensives amid weakness in technology, with sector breadth and recent strength supporting the bullish case. Many also point to a rebound from technical support, while some warn the rally may be extended or due for a pullback; options activity shows no clear directional consensus.

Grayscale Ethereum Trust (ETH) operates as open-end investment company. Its investment objective is for the shares to reflect the value of ETH held by the trust. The company was founded on December 13, 2017 and is headquartered in Stamford, CT.

Grayscale Ethereum Staking Mini ETF - Common units of fractional undivided beneficial interest

Grayscale Ethereum Mini Trust

Ethereums volatile price action alongside broader crypto-market swings is the dominant topic, with traders debating whether recent moves signal a durable recovery or a temporary bounce. Bullish voices point to institutional adoption, ETF activity and tokenization, while cautious traders focus on weak momentum and ETHs underperformance.

Okta, Inc. engages in the provision of an identity management platform for enterprises. The firm operates through the following geographical segments: United States and International. Its products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Okta is drawing attention amid a selloff and valuation concerns, with traders comparing its slower growth and higher sales multiple unfavorably with SentinelOne. Bears worry that workforce cuts and AI agents could pressure per-user identity revenue, while bulls argue that securing AI agents could create new demand; options chatter has also leaned bearish.

Airbnb, Inc. engages in the management and operation of an online marketplace. Its marketplace model connects hosts and guests online or through mobile devices to book spaces. The company was founded by Brian Chesky, Nathan Blecharczyk and Joseph Gebbia in 2007 and is headquartered in San Francisco, CA.

Airbnb Inc - Ordinary Shares - Class A

Airbnb Inc

Airbnbs stronger-than-expected quarterly results and raised revenue-growth outlook have driven a sharp post-earnings rally, with a sizable new buyback authorization adding to the bullish reaction. Some traders remain cautious about the lower take rate, payment-timing effects and margin pressures, as well as risks to discretionary travel demand.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$VLO $XOM $CVX $BP  There is enough oil in the U.S. but not in the rest of the world, which raises the U.S. price. There is also enough natural gas in the U.S. On Friday, natural gas closed at just $2.89/mmBTU, while the European price keeps expanding the gap to the U.S. price. European natural gas closed on Friday at 103.94 EUR/Mwh, which comes out to $34.14/mmBTU in dollars, making it close to 12 times more expensive to Europeans than to Americans.

In Europe and most places in Asia, there is not enough oil produced domestically, and there sure isn’t enough natural gas, as the war in Ukraine has resulted in disruption of pipeline supplies. The Europeans thought they could make it up with more expensive LNG, and the evidence so far is that they cannot do that, as there is damage to Qatari LNG infrastructure, raising spot LNG prices globally. Some industries cannot operate profitably at current natural gas prices. Add diesel at all-time highs, and we have a problem.

TopOptionsAlerts®

Dillon Conners

StockTwits For Android 

Valero Energy Corp.

Exxon Mobil Corp

Chevron Corp.

BP PLC

  There is enough oil in the U.S. but not in the rest of the world, which raises the U.S. price. There is also enough natural gas in the U.S. On Friday, natural gas closed at just $2.89/mmBTU, while the European price keeps expanding the gap to the U.S. price. European natural gas closed on Friday at 103.94 EUR/Mwh, which comes out to $34.14/mmBTU in dollars, making it close to 12 times more expensive to Europeans than to Americans.

In Europe and most places in Asia, there is not enough oil produced domestically, and there sure isn’t enough natural gas, as the war in Ukraine has resulted in disruption of pipeline supplies. The Europeans thought they could make it up with more expensive LNG, and the evidence so far is that they cannot do that, as there is damage to Qatari LNG infrastructure, raising spot LNG prices globally. Some industries cannot operate profitably at current natural gas prices. Add diesel at all-time highs, and we have a problem.

Iranian leader said Friday that Trump is begging them for a deal and they&#39;re not budging, so strikes will happen this week.  This makes the third decapitation attempt on this mythological three headed monster.

Iranian leader said Friday that Trump is begging them for a deal and they're not budging, so strikes will happen this week.  This makes the third decapitation attempt on this mythological three headed monster.